【摘 要】
:
Objective:Analyze the changes and significance of serum IL-6,IL-15 level in juvenile rheumatoid arthritis patients.Methods:Collect serum samples of 31 cases of juvenile rheumatoid arthritis children a
【机 构】
:
广州市妇女儿童医疗中心过敏免疫风湿病科
【出 处】
:
中华医学生物免疫学会第二届学术年会
论文部分内容阅读
Objective:Analyze the changes and significance of serum IL-6,IL-15 level in juvenile rheumatoid arthritis patients.Methods:Collect serum samples of 31 cases of juvenile rheumatoid arthritis children and 16 cases of healthy children,detect the IL-6,IL-15 mass concentration with LuminexTM-1 00 liquid analysis platform.Results:It had a higher level of IL-6,IL-15 in the acute and remission period of juvenile rheumatoid arthritis patients than those in normal control group,the gap was statistically significant (p<0.05).
其他文献
目的 观察细胞因子诱导的杀伤细胞(CIK细胞)与同源树突状细胞(DC细胞)共培养后诱导形成的DCIK细胞的体外细胞毒活性及其治疗肝癌的近期临床疗效、免疫学活性及副反应。方法 收录37例晚期肝癌患者,体外诱导出DC和CIK细胞共培养,诱导形成DCIK细胞,流式分析检测其表型,MTT法检测其体外对人肝癌SMCC-7721和HepG2细胞的杀伤活性。所有患者均接受一定剂量的DCIK细胞过继免疫治疗,观察
Background/Aims:To observe the clinical efficacy of anti-HBV-DC vaccine,the dendritic cells originating from peripheral blood mononuclear cells(PBMC) sensitized by HBsAg,in combination with lamivudine
Background/Aims:To observe the clinical efficacy of anti-HBV-DC vaccine,the dendritic cells originating from peripheral blood mononuclear cells(PBMC) sensitized by HBsAg,in combination with thymosin-α
Background/Aims:To observe the clinical efficacy of anti-HBV-DC vaccine,the dendritic cells originating from peripheral blood mononuclear cells(PBMC) sensitized by HBsAg,in combination with thymosin-α
Background/Aims:To observe the clinical efficacy of anti-HBV-DC vaccine,the dendritic cells originating from peripheral blood mononuclear cells(PBMC) sensitized by HBsAg,in combination with lamivudine
Background:The cysteine protease inhibitor Cystatin C (CstC) is linked to diseases in both quantity and quality.Low extracellular CstC is associated with elevated protease activity in cancer,arthritis
Aims:To observe the clinical efficacy of anti-HBV-DC-MTL,the dendritic cells(DC) and mixed T lymphocyte(MTL)originating from PBMC sensitized by HBsAg,in HBeAg negative chronic hepatitis B virus(HBV) i
Background and aims:To observe the clinical efficacy of anti-HBV-DC vaccine,the dendritic cells(DC) originating from peripheral blood mononuclear cells(PBMC) sensitized by HBsAg,in combination with la
Aims:To observe the clinical efficacy of anti-HBV-DC vaccine,the dendritic cells originating from peripheral blood mononuclear cells(PBMC) sensitized by HBsAg,in combination with thymosin-α 1,in the H
Objective Observe the cIinical effects and features of tumor necrosis factor antagonists (Etanercept) in treatment of systemic onset juvenile idiopathic arthritis (So-JIA),to provide the basis evidenc